# The Efficacy and Safety of Entecavir Treatment of Patients With Acute on Chronic Hepatitis B Liver Failure

> **NCT01254994** · PHASE2 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 108 (actual)

## Conditions studied

- Liver Failure

## Interventions

- **DRUG:** entecavir
- **DRUG:** Traditional comprehensive medical treatment

## Key facts

- **NCT ID:** NCT01254994
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2009-07
- **Final completion:** 2010-12
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2010-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01254994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01254994, "The Efficacy and Safety of Entecavir Treatment of Patients With Acute on Chronic Hepatitis B Liver Failure". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01254994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*